Shopping Cart
- Remove All
Your shopping cart is currently empty
(R)-Thalidomide
😃Good
Catalog No. T12644Cas No. 2614-06-4
Alias (R)-(+)-Thalidomide
(R)-Thalidomide is the R-enantiomer of Thalidomide, has sedative properties.
(R)-Thalidomide
😃Good
Catalog No. T12644Alias (R)-(+)-ThalidomideCas No. 2614-06-4
(R)-Thalidomide is the R-enantiomer of Thalidomide, has sedative properties.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $65 | 7-10 days | |
| 5 mg | $157 | 7-10 days | |
| 10 mg | $253 | 7-10 days | |
| 25 mg | $428 | 7-10 days | |
| 50 mg | $619 | 7-10 days | |
| 100 mg | $877 | 7-10 days |
Bulk & Custom
Add to Cart
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Chemical Properties
| Description | (R)-Thalidomide is the R-enantiomer of Thalidomide, has sedative properties. |
| In vitro | With the affinity of (R)-Thalidomide by the MIP present surface capture, that is more strongly than the other forms. In the case of (R)-Thalidomide, it is found to bind to the selective sites of the MIP more strongly than the other which reflects their different biological entities[1]. The (S)-Thalidomide imprints MIP nanoparticles exerted a greater cytotoxic effect on the caco-2 cells than the (R)-Thalidomide imprinted MIPs[1]. |
| In vivo | Effectiveness of oral thalidomide alone, and with intraperitoneal BCNU or cisplatin combination chemotherapy, is assessed after several weeks treatment. Both serum and tissue concentrations of (R)-thalidomide are 40-50% greater than those of (S)-thalidomide. Co-administration of BCNU or cisplatin with thalidomide did not alter the concentration enantioselectivity[1]. |
| Alias | (R)-(+)-Thalidomide |
| Molecular Weight | 258.23 |
| Formula | C13H10N2O4 |
| Cas No. | 2614-06-4 |
| Relative Density. | 1.503g/cm3 |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy (R)-Thalidomide | purchase (R)-Thalidomide | (R)-Thalidomide cost | order (R)-Thalidomide | (R)-Thalidomide chemical structure | (R)-Thalidomide in vivo | (R)-Thalidomide in vitro | (R)-Thalidomide formula | (R)-Thalidomide molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.